EBQ:San Francisco Syncope Rule

From WikEM
(Redirected from San Francisco Syncope Rule)
Jump to: navigation, search
Complete Journal Club Article
Quinn J. et al.. "Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes". Ann Emerg Med. 2006. 31(26):2992-6.
PubMed Full text PDF

Clinical Question

Can the San Francisco Syncope Rule be used in clinical practice to risk stratify patients presenting with syncope?

Conclusion

  • The San Francisco Syncope Rule demonstrated to be highly sensitive (98% sensitivity, 95% CI 89-100%) but not very specific (56%, 95% CI 52-60%) for predicting serious outcomes.

Major Points

Criteria (CHESS Pneumonic)[1]

The rule is positive if any of the above apply to the patient.

Study Design

  • A prospective cohort study
  • N =: 760 patients had 791 visits for syncope (1.2% of all ED visits)
  • Consecutive patients with syncope or near syncope presenting to an emergency department of a large, urban teaching hospital were identified and enrolled from July 15, 2002 to August 31, 2004
  • Physicians prospectively applied the San Francisco Syncope Rule
    • Patient follow up performed to determine if the patient suffered a predefined serious outcome within 30 days of their ED visit
    • Physicians completed a short Web-based form and enrolled patients after their assessment
    • Study investigators reviewed all data forms in order to ensure the correct interpretation of the rule
  • 30 day follow-up completed after patients' index ED visit to determine short-term outcomes that would require admission
    • Short-term serious outcomes defined as:
      • Death
      • Myocardial Infarction
        • Any elevation of troponin or ECG change with an accompanying diagnosis of myocardial infarction on D/C and confirmed by the cardiology service or primary physician
      • Arrhythmia
      • Pulmonary Embolism
        • Needed to have received treatment for the pulmonary embolism or had it confirmed on autopsy
      • Stoke
      • Subarachnoid Hemorrhage
      • Significant Hemorrhage or Anemia Requiring Transfusion
      • Procedural intervention to treat a related cause of syncope or any condition causing or likely to cause a return ED visit
      • Hospitalization for a related event

Population

Patient Demographics

  • 364 men, 427 females
  • Mean age: 61
  • Admitted: 469 (59%)
  • Patients with serious outcomes after ED visit: 54 (6.8%)
    • Death: 3
    • Arrhythmia: 23
    • Myocardial Infarction: 11
    • Valvular Heart Disease: 1
    • Significant Hemorrhage: 7
    • TIA/Stroke: 3
    • Sepsis: 3
    • Admission after ED Discharge : 3

Inclusion Criteria

  • Consecutive patients presenting with syncope or near syncope without any of the predefined exclusion criteria

Exclusion Criteria

  • Trauma-related loss of consciousness
  • Alcohol-related loss of consciousness
  • Drug-related loss of consciousness
  • Definite seizure
  • LOC associated with an altered level of consciousness or persistent new neurologic deficits did not meet operational definition of syncope and were excluded

Interventions

Outcomes

  • 30 day follow-up after the patients' index ED visit to determine serious short-term outcomes
  • Serious short-term outcomes defined as: death, myocardial infarction, arrhythmia, pulmonary embolism, stroke, subarachnoid hemorrhage, significant hemorrhage or anemia requiring transfusion, procedural intervention to treat a related cause of syncope or any condition likely to cause a return ED visit, and hospitalization for a related event

Primary Outcome

  • Patients with serious outcomes after ED visit: 54 (6.8%)

Performance of the San Francisco Syncope Rule in the validation cohort

Decision Rule Yes No
Rule Positive 52 290
Rule Negative 1 370
  • Sensitivity 98% (95% CI 89% to 100%)
  • Specificity 56% (95% CI 52% to 60%)
  • Negative Predictive Value 99.7% (95% CI 98% to 100%)
  • Positive Predictive Value 15% (95% CI 12% to 20%)
  • Death: 3
  • Arrhythmia: 23
  • Myocardial Infarction: 11
  • Valvular Heart Disease: 1
  • Significant Hemorrhage: 7
  • TIA/Stroke: 3
  • Sepsis: 3
  • Admission after ED discharge: 3

Secondary Outcomes

  • Physicians accurately interpreted the rule 95% of the time
    • Physicians felt comfortable using the rule in 79% of the cases
    • Physicians felt neutral using the rule in 15% of cases
    • Physicians felt uncomfortable using the rule in 6% of cases
  • The San Francisco Syncope Rule would have classified 52% of the patients as high risk
    • Using the rule potentially would have decreased overall admissions by 7%
    • Applying the rule to only the 453 patients admitted might have decreased admissions by 24%

Subgroup analysis

Criticisms & Further Discussion

  • Patients from only one hospital enrolled in the study
  • Validation study is performed at the same center used to derive the original rule
  • Wide margin of error observed in sensitivity[2]
    • 98% [95% confidence interval 89% to 100%). Taking the lower limit of the confidence interval as the correct value, the clinical decision rule cannot be considered highly sensitive
      • For example, in 100 patients with syncope of undetermined cause on presentation, 11 discharged home could have an adverse outcome
  • 54 patients has serious outcomes, but only 53 patients had data forms prospectively completed. The patient without a data form was excluded from the sensitivity analysis

Funding

  • A career development grant from the National Institutes of Health available to Dr. James Quinn, MD, MS, primary investigator of the study

Further Reading

ACEP Clinical Practice Management: Management of Syncope

Complete Journal Club Article
Martin TP et al.. "Risk stratification of patients with syncope". Ann Emerg Med. 1997. 29:459-466.
PubMed
Complete Journal Club Article
Colivicchi F et al. "Development and prospective validation of a risk stratification system for patients with syncope in the emergency department: the OESIL risk score". Eur Heart J.. 2003. 24:811-819.
PubMed
Complete Journal Club Article
Sarasin FP, Hanusa BH, Perneger T, et al.. "A risk score to predict arrhythmias in patients with unexplained syncope". Acad Emerg Med. 2003. 10:1312-1317.
PubMed

See Also

References

  1. ↑ Quinn J, McDermott D, Stiell I, Kohn M, Wells G. Prospective validation of the San Francisco Syncope Rule to predict patients with serious outcomes. Ann Emerg Med. 2006 May;47(5):448-54. PubMed PMID: 16631985.
  2. ↑ Miller C, Hoekstra J. Prospective Validation of the San Francisco Syncope Rule: Will It Change Practice? Ann Emerg Med. 2006 May;47(5):455-56. PubMed PMID: 16631986